This label-based guidance removes guesswork from travel scheduling
These medicines, administered by injection daily or weekly, can promote weight loss
(Comparison) (Intervention) GLP-1 (GLP-1 receptor agonist) (Comparator) SGLT-2 (SGLT-2 inhibitor)* GLP-1 SUD () 1,000 GLP-1 GLP-1 GLP-1 1,000 GLP-1 *SGLT-2: --2 () (Net risk difference) BMJ Visual Abstract (2026)
Most important is, however, that the tests used may give hints to the clinician for a better, more timed treatment of the disease accordingly to our present knowledge
Based on Fact.MR analysis, demand for GLP-1 companion products is estimated to grow to around USD 5.2 billion in 2026 and USD 14.4 billion by 2036
Most users who follow a structured BRAT diet during dose-escalation weeks see symptoms ease within 2472 hours without needing medication